甲胺相关的乳酸 (MALA):当一个常见的药物变成灾难性的
Lauren E Kessler1, Dheerja Sachdeva2, Rohan Singhal3
1Nephrology, Edward Via College of Osteopathic Medicine, Auburn, USA.
Cureus
|September 4, 2025
概括
在患有脏疾病的患者中,甲福明可引起乳酸性. 早期诊断和透析对于康复至关重要,尤其是在糖尿病和脏疾病的老年患者中.
科学领域:
- 内分泌学
- 肝脏病学
- 药理学
背景情况:
- 甲胺是2型糖尿病的主要治疗方法.
- 功能受损增加了与甲胺相关的乳酸性瘤 (MALA) 的风险.
- MALA是一种罕见但严重的并发症,需要差异诊断.
研究的目的:
- 突出识别与甲胺相关的乳酸 (MALA) 的关键重要性.
- 强调替代疗法在治疗MALA中的作用.
- 介绍一位患有并存疾病的老年患者的病例研究.
主要方法:
- 一个88岁的女性患有2型糖尿病和CKDIII期的病例报告.
- 详细的临床表现包括严重的乳酸和脑病变.
- 使用抗生素,血液动力学支持和急诊透析.
主要成果:
- 尽管初步治疗,患者的病情迅速恶化.
- 紧急透析导致显著的临床和生化改善.
- 对透析的反应支持了MALA的诊断.
结论:
- 早期识别MALA至关重要,特别是在功能下降的老年患者中.
- 差异诊断对于排除乳酸性酸性疾病的其他原因至关重要.
- 置换疗法是对MALA治疗和改善结果的关键干预措施.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Diabetes: Symptoms, Diagnosis, and Complications
684
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
684
Dipeptidyl Peptidase 4 Inhibitors
249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249
Inborn Errors of Metabolism
239
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
239
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K


